On July 28, 2025, in Beijing, China, WixBio completed another delivery of 11,000 vials of customized poultry vaccine to clients in Iraq.
Building on trust in product quality and consistent market acclaim, Iraqi clients reordered 10,500 vials of the 500ml Newcastle Disease (ND), Avian Influenza (AI), and Fowl Adenovirus (FADV) triple-inactivated vaccine (referred to as “ND-AI-FADV inactivated vaccine”). This order underscores the strong recognition of WixBio’s products and their established reputation in the Iraqi market.
Specifically formulated for poultry disease patterns in the Middle East, this ND-AI-FADV inactivated vaccine provides robust and broad-spectrum protection. Each batch undergoes rigorous quality control testing to ensure consistent immunogenicity and high protective efficacy. Feedback from Iraqi clients confirms that the vaccine significantly elevates poultry antibody titers and effectively reduces disease incidence, earning widespread praise from local farmers and veterinary professionals.
To maintain vaccine potency and integrity during transport, WixBio implements a comprehensive cold-chain logistics system, supported by GPS temperature monitoring, ensuring every vial arrives in optimal condition.
WixBio’s Head of Overseas Sales commented: “We are delighted by the continued confidence and support from our Iraqi clients. This order reflects not only the quality of our products but also our commitment to delivering superior animal health solutions worldwide.”
This successful order strengthens WixBio’s foothold in the Middle East market, highlighting its dedication and capability to expand globally. Moving forward, WixBio will continue to advance research and development, as well as technical innovation, to provide high-quality, reliable animal health products to more countries and regions.
